Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DR26FCRE0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,091
Award facts
- Contract value 100% obligated
- $13,091.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $13,091.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ILARIS 150 mg/mL vials. The delivery order was issued on October 20, 2025, with an ultimate completion date of November 10, 2025. No set-aside designation was applied to this award, indicating the vendor competed unrestricted in the federal procurement process. DMS Pharmaceutical Group Inc. will perform the work in Park Ridge, Illinois, and no subcontractors are identified in the award documentation.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group's consistent performance across numerous delivery orders issued by DLA's Medical Supply Chain division demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCRE0?
SPE2DR26FCRE0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FCRE0 worth?
The government has obligated $13,091 on SPE2DR26FCRE0.
Is contract SPE2DR26FCRE0 an order under another contract?
Yes. SPE2DR26FCRE0 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRE0 competed?
The extent of competition for SPE2DR26FCRE0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award